Transaction · 0001780088-26-000021

Ticho Barry

Ticho Barry, CMO, reported an open-market or private sale at Stoke Therapeutics, Inc. involving 1600.000000 shares for an estimated $49691.04. Reported holdings after the transaction were 20110.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCMO
STOKStoke Therapeutics, Inc.
Filing timeSep 03
Trade dateSep 01, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$29.99
Pre-filing
1mo ago -3.8%1w ago +12.5%1d ago +4.0%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

STOK price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
STOK since 2026-09-03Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001780088-26-000021
Common Stock
Transaction date
Sep 01, 2026
Filed Sep 03, 2026, 08:17 PM · 2d delay
Shares
1.60k sh
$3.10k per share
Estimated value
-$4.96M
Computed from shares × price
Holdings after
20.1k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF MEDICAL OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025.

  2. F2

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.94 to $30.92 per share, inclusive. The reporting person undertake…

  3. F3

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.96 to $31.20 per share, inclusive.

Original filing · 0001780088-26-000021
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

STOK